Log in
Enquire now

List of Foundation Medicine patents

List of Foundation Medicine patents
List of sphingotec patents
List of Tempus Labs (company) patents
List of Gradalis patents
List of awards received by Nicki Minaj
List of awards received by Dolly Parton
Patents where
Current Assignee
Name
is
Foundation MedicineFoundation Medicine
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9340830 Optimization of multigene analysis of tumor samples

Patent 9340830 was granted and assigned to Foundation Medicine on May, 2016 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
9340830
May 17, 2016
‌
US Patent 11158425 System and method for managing genomic information

Patent 11158425 was granted and assigned to Foundation Medicine on October, 2021 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
11158425
October 26, 2021
‌
US Patent 11450438 System and method for outcome tracking and analysis

Patent 11450438 was granted and assigned to Foundation Medicine on September, 2022 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
11450438
September 20, 2022
‌
US Patent 11136619 Optimization of multigene analysis of tumor samples

Patent 11136619 was granted and assigned to Foundation Medicine on October, 2021 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
11136619
October 5, 2021
‌
US Patent 11118213 Optimization of multigene analysis of tumor samples

Patent 11118213 was granted and assigned to Foundation Medicine on September, 2021 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
11118213
September 14, 2021
‌
US Patent 9297011 KIF5B-RET fusion molecules and uses thereof

Patent 9297011 was granted and assigned to Foundation Medicine on March, 2016 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
9297011
March 29, 2016
‌
US Patent 11421265 Optimization of multigene analysis of tumor samples

Patent 11421265 was granted and assigned to Foundation Medicine on August, 2022 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
11421265
August 23, 2022
‌
US Patent 11578372 NTRK1 fusion molecules and uses thereof

Patent 11578372 was granted and assigned to Foundation Medicine on February, 2023 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
11578372
February 14, 2023
‌
US Patent 10093983 Estrogen receptor mutations and uses thereof

Patent 10093983 was granted and assigned to Foundation Medicine on October, 2018 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
10093983
October 9, 2018
‌
US Patent 9792403 Analysis of genetic variants

Patent 9792403 was granted and assigned to Foundation Medicine on October, 2017 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
9792403
October 17, 2017
‌
US Patent 11230589 Fusion molecules and uses thereof

Patent 11230589 was granted and assigned to Foundation Medicine on January, 2022 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
11230589
January 25, 2022
‌
US Patent 10000814 ALK and NTRK1 fusion molecules and uses thereof

Patent 10000814 was granted and assigned to Foundation Medicine on June, 2018 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
10000814
June 19, 2018
‌
US Patent 9610288 Methods of treating urothelial carcinoma

Patent 9610288 was granted and assigned to Foundation Medicine on April, 2017 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
9610288
April 4, 2017
‌
US Patent 9884060 KIF5B-RET fusion molecules and uses thereof

Patent 9884060 was granted and assigned to Foundation Medicine on February, 2018 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
9884060
February 6, 2018
‌
US Patent 11098368 ALK and NTRK1 fusion molecules and uses thereof

Patent 11098368 was granted and assigned to Foundation Medicine on August, 2021 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
11098368
August 24, 2021
‌
US Patent 9861633 Methods of treating urothelial carcinoma

Patent 9861633 was granted and assigned to Foundation Medicine on January, 2018 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
9861633
January 9, 2018
‌
US Patent 11286532 Estrogen receptor mutations and uses thereof

Patent 11286532 was granted and assigned to Foundation Medicine on March, 2022 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
11286532
March 29, 2022
‌
US Patent 10980804 Methods of treating cholangiocarcinoma

Patent 10980804 was granted and assigned to Foundation Medicine on April, 2021 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
10980804
April 20, 2021
‌
US Patent 10847249 Analysis of genetic variants

Patent 10847249 was granted and assigned to Foundation Medicine on November, 2020 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
10847249
November 24, 2020
‌
US Patent 12087453 System and method for outcome tracking and analysis

Patent 12087453 was granted and assigned to Foundation Medicine on September, 2024 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
12087453
September 10, 2024
‌
US Patent 12116638 Estrogen receptor mutations and uses thereof

Patent 12116638 was granted and assigned to Foundation Medicine on October, 2024 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
12116638
October 15, 2024
‌
US Patent 11771698 Methods of treating cholangiocarcinoma

Patent 11771698 was granted and assigned to Foundation Medicine on October, 2023 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
11771698
October 3, 2023
‌
US Patent 11959141 Multigene analysis of tumor samples

Patent 11959141 was granted and assigned to Foundation Medicine on April, 2024 by the United States Patent and Trademark Office.

Foundation Medicine
Foundation Medicine
Foundation Medicine
Foundation Medicine
United States Patent and Trademark Office
United States Patent and Trademark Office
11959141
April 16, 2024
23 results
0 selected
23 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us